Bronson Methodist Hospital and Bronson Advanced Cardiac Healthcare are celebrating 13 years of performing transcatheter aortic valve replacement (TAVR), a minimally invasive procedure that has given ...
Washington, D.C. – May 2, 2025 – New analysis from the EARLY TAVR trial showed patients between the age of 65 and 70 years old derived the most benefits of a strategy of early intervention with ...
People with severe aortic stenosis, a condition where the heart’s aortic valve narrows and restricts blood flow, can already undergo a less invasive and faster procedure compared to traditional ...
A team of cardiologists emphasized the importance of offering modern surgical options custom-tailored and curated for each patient in today’s medical field.
Patients who underwent transcatheter aortic valve replacement (TAVR) with a valve designed to treat aortic regurgitation had an overall mortality rate of just 8.1% at one year, well below the trial's ...
A device designed to remove embolic material—fragments of tissue that can be released into the bloodstream during transcatheter aortic valve replacement (TAVR)—did not result in a reduction in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results